MGX
Metagenomi Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$1.475
Haut
$1.475
Bas
$1.475
Volume
0.25M
Fondamentaux de l'Entreprise
Statistiques de Trading
Actualités Connexes
Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12
Chardan Capital analyst Geulah Livshits maintains Metagenomi with a Buy and lowers the price target from $13 to $12.
Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $16
Wells Fargo analyst Yanan Zhu maintains Metagenomi with a Overweight and lowers the price target from $20 to $16.
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate
Metagenomi to Present at Upcoming Scientific Meetings
EMERYVILLE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing
Actions Connexes
DRMA
Dermata Therapeutics Inc.
HYT
Blackrock Corporate High Yield Fund Inc.
WTFCP
Wintrust Financial Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of 6.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series E
LARK
Landmark Bancorp Inc.
LILAK
Liberty Latin America Ltd. Class C
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.